Cargando…

Life without Perlecan Has Its Problems

Detalles Bibliográficos
Autor principal:	Olsen, Bjorn R.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1999
Materias:	Mini-Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2169336/ https://www.ncbi.nlm.nih.gov/pubmed/10579711

Ejemplares similares

Membrane Packing Problems: A short Review on computational Membrane Modeling Methods and Tools
por: Sommer, Björn
Publicado: (2013)

Perlecan: a review of its role in neurologic and musculoskeletal disease
por: Lavorgna, Tessa R., et al.
Publicado: (2023)

Expression of the Heparan Sulfate Proteoglycan, Perlecan, during Mouse Embryogenesis and Perlecan Chondrogenic Activity In Vitro
por: French, M.M., et al.
Publicado: (1999)

Modular Proteoglycan Perlecan/HSPG2: Mutations, Phenotypes, and Functions
por: Martinez, Jerahme R., et al.
Publicado: (2018)

Perlecan controls neurogenesis in the developing telencephalon
por: Girós, Amparo, et al.
Publicado: (2007)

Review of Alterations in Perlecan-Associated Vascular Risk Factors in Dementia
por: Trout, Amanda L., et al.
Publicado: (2020)

Prolactin and cancer: Has the orphan finally found a home?
por: Sethi, Bipin Kumar, et al.
Publicado: (2012)

Evolution of the Perlecan/HSPG2 Gene and Its Activation in Regenerating Nematostella vectensis
por: Warren, Curtis R., et al.
Publicado: (2015)

Perlecan and the Blood-Brain Barrier: Beneficial Proteolysis?
por: Roberts, Jill, et al.
Publicado: (2012)

Perlecan and synaptophysin changes in denervated skeletal muscle☆
por: Ma, Kai, et al.
Publicado: (2012)

Increased Risk of Aortic Dissection with Perlecan Deficiency
por: Nonaka, Risa, et al.
Publicado: (2021)

Similarity of Recombinant Human Perlecan Domain 1 by Alternative Expression Systems Bioactive Heterogenous Recombinant Human Perlecan D1
por: Ellis, April L, et al.
Publicado: (2010)

The Heterogeneity of ER Ca(2+) Stores Has a Key Role in Nonmuscle Cell Signaling and Function
por: Meldolesi, Jacopo, et al.
Publicado: (1998)

Tissue guidance without filopodia
por: Wacker, Andrin, et al.
Publicado: (2014)

Restoring vision using optogenetics without being blind to the risks
por: Harris, Alexander R., et al.
Publicado: (2021)

Acetylcholinesterase Clustering at the Neuromuscular Junction Involves Perlecan and Dystroglycan
por: Peng, H. Benjamin, et al.
Publicado: (1999)

Perlecan Maintains the Integrity of Cartilage and Some Basement Membranes
por: Costell, Mercedes, et al.
Publicado: (1999)

Lessons from Mice without Telomerase
por: Lansdorp, Peter M.
Publicado: (1997)

A new approach to comparing problem solving, flexibility and innovation
por: Auersperg, Alice M.I., et al.
Publicado: (2012)

Rapid growth of antimicrobial resistance: the role of agriculture in the problem and the solutions
por: Stanley, Dragana, et al.
Publicado: (2022)

GC/MS in Recent Years Has Defined the Normal and Clinically Disordered Steroidome: Will It Soon Be Surpassed by LC/Tandem MS in This Role?
por: Shackleton, Cedric, et al.
Publicado: (2018)

A central function for perlecan in skeletal muscle and cardiovascular development
por: Zoeller, Jason J., et al.
Publicado: (2008)

Perlecan Maintains Microvessel Integrity In Vivo and Modulates Their Formation In Vitro
por: Gustafsson, Erika, et al.
Publicado: (2013)

Perlecan regulates bidirectional Wnt signaling at the Drosophila neuromuscular junction
por: Kamimura, Keisuke, et al.
Publicado: (2013)

What Are the Potential Roles of Nuclear Perlecan and Other Heparan Sulphate Proteoglycans in the Normal and Malignant Phenotype
por: Hayes, Anthony J., et al.
Publicado: (2021)

Scarring the early-life microbiome: its potential life-long effects on human health and diseases
por: Park, Hyunji, et al.
Publicado: (2023)

Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients
por: Grindel, Brian, et al.
Publicado: (2016)

Recent advances in functional region prediction by using structural and evolutionary information – Remaining problems and future extensions
por: Nemoto, Wataru, et al.
Publicado: (2013)

PNPLA3-I148M: a problem of plenty in non-alcoholic fatty liver disease
por: BasuRay, Soumik
Publicado: (2019)

Agrin and Perlecan Mediate Tumorigenic Processes in Oral Squamous Cell Carcinoma
por: Kawahara, Rebeca, et al.
Publicado: (2014)

Cancer Metastasis: The Role of the Extracellular Matrix and the Heparan Sulfate Proteoglycan Perlecan
por: Elgundi, Zehra, et al.
Publicado: (2020)

Insulin and Glucagon: Partners for Life
por: Holst, Jens Juul, et al.
Publicado: (2017)

Correction: Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients
por: Grindel, Brian, et al.
Publicado: (2016)

Perlecan, A Multi-Functional, Cell-Instructive, Matrix-Stabilizing Proteoglycan With Roles in Tissue Development Has Relevance to Connective Tissue Repair and Regeneration
por: Hayes, Anthony J., et al.
Publicado: (2022)

Effects of calorie restriction on life span of microorganisms
por: Skinner, Craig, et al.
Publicado: (2010)

Influenza A: Understanding the Viral Life Cycle
por: Samji, Tasleem
Publicado: (2009)

The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda
por: Fliser, Danilo, et al.
Publicado: (2011)

The glycosylation-dependent interaction of perlecan core protein with LDL: implications for atherosclerosis
por: Xu, Yu-Xin, et al.
Publicado: (2015)

Perlecan is recruited by dystroglycan to nodes of Ranvier and binds the clustering molecule gliomedin
por: Colombelli, Cristina, et al.
Publicado: (2015)

Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer
por: Khanna, Vidhi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d9ih83mtqrfv5ctbcul4ac7j6b